Molina Healthcare Reports First Quarter 2024 Financial Results

Reaffirms Full Year 2024 Guidance

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.73. Financial results are summarized below:

 

Three months ended

 

March 31,

 

2024

 

2023

 

 

 

 

(In millions, except per-share results)

Premium Revenue

$9,504

 

$7,885

Total Revenue

$9,931

 

$8,149

 

 

 

 

GAAP:

 

 

 

Net Income

$301

 

$321

EPS – Diluted

$5.17

 

$5.52

Medical Care Ratio (MCR)

88.5%

 

87.1%

G&A Ratio

7.2%

 

7.2%

After-tax Margin

3.0%

 

3.9%

 

 

 

 

Adjusted:

 

 

 

Net Income

$334

 

$337

EPS – Diluted

$5.73

 

$5.81

G&A Ratio

7.1%

 

7.2%

After-tax Margin

3.4%

 

4.1%

 

 

 

 

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Quarter Highlights

  • As of March 31, 2024, the Company served approximately 5.7 million members, an increase of 9% compared to March 31, 2023.
  • Premium revenue was approximately $9.5 billion for the first quarter of 2024, an increase of 21% year over year.
  • GAAP net income was $5.17 per diluted share for the first quarter of 2024, a decrease of 6% year over year.
  • Adjusted net income was $5.73 per diluted share for the first quarter of 2024, a decrease of 1% year over year.
  • The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share.

“We are very pleased with our first quarter performance,” said Joseph Zubretsky, President and Chief Executive Officer. “We delivered strong financial performance supported by excellent operating metrics across our business, while sustaining profitable growth consistent with our long-term targets.”

Premium Revenue

Premium revenue was approximately $9.5 billion for the first quarter of 2024, an increase of 21% year over year. The higher premium revenue reflects new contract wins, acquisitions, and growth in the current footprint, partially offset by Medicaid redeterminations.

Net Income

GAAP net income for the first quarter of 2024 was $5.17 per diluted share, a decrease of 6% year over year. Adjusted net income for the first quarter of 2024 was $5.73 per diluted share, a decrease of 1% year over year. The year over year decrease in earnings per share reflects a shift in the quarterly earnings pattern based on the significant increase in new business in 2024.

Medical Care Ratio (MCR)

  • The consolidated MCR for the first quarter of 2024 was 88.5%, reflecting changes in member mix due to growth across all segments and continued, strong medical cost management, and is in line with the Company’s expectation.
  • The Medicaid MCR for the first quarter of 2024 was 89.7%, in line with the Company’s expectation and normal quarter to quarter trend fluctuations within our guidance. The new store additions in California and Nebraska, as well as Iowa and the My Choice Wisconsin acquisition in late-2023, drove a higher reported MCR in the first quarter of 2024.
  • The Medicare MCR for the first quarter of 2024 was 88.7%, in line with the Company’s expectations. Utilization in the legacy portfolio was consistent with the second half of 2023, but was offset by operational improvements and benefit adjustments.
  • The Marketplace MCR for the first quarter of 2024 was 73.3%, reflecting the Company’s pricing strategy and seasonality.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the first quarter of 2024 was 7.2% and 7.1%, respectively.

Balance Sheet

Cash and investments at the parent company were $194 million as of March 31, 2024 compared to $742 million as of December 31, 2023.

Days in claims payable at March 31, 2024 was 49.

Cash Flow

Operating cash flow for the three months ended March 31, 2024 was $214 million, compared to $916 million for the three months ended March 31, 2023. The decrease in 2024 cash flow was driven by the net impact of timing differences in government receivables and payables.

2024 Guidance

Premium revenue for the full year is expected to be approximately $38 billion, an increase of approximately 17% from the full year 2023.

The Company expects its full year adjusted earnings per diluted share in 2024 to be at least $23.50, representing approximately 13% growth over the full year 2023. While the Company is experiencing underlying strength in its core business, its full year guidance is unchanged to account for any potential earnings headwind in the second half of the year from potential contract losses in Virginia and Florida.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s first quarter results at 8:00 a.m. Eastern Time on Thursday, April 25, 2024. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 0974846. A telephonic replay of the conference call will be available through Thursday, May 9, 2024, by dialing (877) 344-7529 and entering confirmation number 7039934. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding its 2024 guidance and long-term targets, expected headwinds, and management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the periods ended March 31, 2024, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of April 24, 2024, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

MOLINA HEALTHCARE, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 

 

 

Three Months Ended

 

 

March 31,

 

 

2024

 

2023

 

 

 

 

 

 

 

(In millions, except per-share amounts)

Revenue:

 

 

 

 

Premium revenue

 

$

9,504

 

$

7,885

Premium tax revenue

 

 

297

 

 

172

Investment income

 

 

108

 

 

71

Other revenue

 

 

22

 

 

21

Total revenue

 

 

9,931

 

 

8,149

Operating expenses:

 

 

 

 

Medical care costs

 

 

8,414

 

 

6,871

General and administrative expenses

 

 

711

 

 

591

Premium tax expenses

 

 

297

 

 

172

Depreciation and amortization

 

 

45

 

 

44

Other

 

 

38

 

 

16

Total operating expenses

 

 

9,505

 

 

7,694

Operating income

 

 

426

 

 

455

Interest expense

 

 

27

 

 

28

Income before income tax expense

 

 

399

 

 

427

Income tax expense

 

 

98

 

 

106

Net income

 

$

301

 

$

321

 

 

 

 

 

Net income per share – Diluted

 

$

5.17

 

$

5.52

 

 

 

 

 

Diluted weighted average shares outstanding

 

 

58.3

 

 

58.0

MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

 

March 31,

 

December 31,

 

 

2024

 

2023

 

 

Unaudited

 

 

 

 

(Dollars in millions,

except per-share amounts)

ASSETS

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

4,513

 

 

$

4,848

 

Investments

 

 

4,424

 

 

 

4,259

 

Receivables

 

 

3,350

 

 

 

3,104

 

Prepaid expenses and other current assets

 

 

381

 

 

 

331

 

Total current assets

 

 

12,668

 

 

 

12,542

 

Property, equipment, and capitalized software, net

 

 

295

 

 

 

270

 

Goodwill and intangible assets, net

 

 

1,927

 

 

 

1,449

 

Restricted investments

 

 

261

 

 

 

261

 

Deferred income taxes, net

 

 

228

 

 

 

227

 

Other assets

 

 

134

 

 

 

143

 

Total assets

 

$

15,513

 

 

$

14,892

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

 

Medical claims and benefits payable

 

$

4,571

 

 

$

4,204

 

Amounts due government agencies

 

 

2,501

 

 

 

2,294

 

Accounts payable, accrued liabilities and other

 

 

1,114

 

 

 

1,252

 

Deferred revenue

 

 

328

 

 

 

418

 

Total current liabilities

 

 

8,514

 

 

 

8,168

 

Long-term debt

 

 

2,180

 

 

 

2,180

 

Finance lease liabilities

 

 

202

 

 

 

205

 

Other long-term liabilities

 

 

124

 

 

 

124

 

Total liabilities

 

 

11,020

 

 

 

10,677

 

Stockholders’ equity:

 

 

 

 

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at March 31, 2024, and 58 million at December 31, 2023

 

 

 

 

 

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

 

 

 

 

 

Additional paid-in capital

 

 

390

 

 

 

410

 

Accumulated other comprehensive loss

 

 

(85

)

 

 

(82

)

Retained earnings

 

 

4,188

 

 

 

3,887

 

Total stockholders’ equity

 

 

4,493

 

 

 

4,215

 

Total liabilities and stockholders’ equity

 

$

15,513

 

 

$

14,892

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

Three Months Ended

 

 

March 31,

 

 

2024

 

2023

 

 

 

 

 

 

 

(In millions)

Operating activities:

 

 

 

 

Net income

 

$

301

 

 

$

321

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

45

 

 

 

44

 

Deferred income taxes

 

 

26

 

 

 

1

 

Share-based compensation

 

 

36

 

 

 

25

 

Other, net

 

 

2

 

 

 

5

 

Changes in operating assets and liabilities:

 

 

 

 

Receivables

 

 

(123

)

 

 

(234

)

Prepaid expenses and other current assets

 

 

8

 

 

 

7

 

Medical claims and benefits payable

 

 

(24

)

 

 

296

 

Amounts due government agencies

 

 

183

 

 

 

270

 

Accounts payable, accrued liabilities and other

 

 

(215

)

 

 

(215

)

Deferred revenue

 

 

(90

)

 

 

295

 

Income taxes

 

 

65

 

 

 

101

 

Net cash provided by operating activities

 

 

214

 

 

 

916

 

Investing activities:

 

 

 

 

Purchases of investments

 

 

(380

)

 

 

(646

)

Proceeds from sales and maturities of investments

 

 

211

 

 

 

371

 

Net cash paid in business combinations

 

 

(295

)

 

 

 

Purchases of property, equipment, and capitalized software

 

 

(27

)

 

 

(32

)

Other, net

 

 

3

 

 

 

5

 

Net cash used in investing activities

 

 

(488

)

 

 

(302

)

Financing activities:

 

 

 

 

Common stock withheld to settle employee tax obligations

 

 

(56

)

 

 

(58

)

Other, net

 

 

(6

)

 

 

(7

)

Net cash used in financing activities

 

 

(62

)

 

 

(65

)

Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents

 

 

(336

)

 

 

549

 

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

 

 

4,908

 

 

 

4,048

 

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

 

$

4,572

 

 

$

4,597

 

MOLINA HEALTHCARE, INC.

UNAUDITED SEGMENT DATA

(Dollars in millions)

 

 

 

March 31,

 

December 31,

 

March 31,

 

 

2024

 

2023

 

2023

Ending Membership by Segment:

 

 

 

 

 

 

Medicaid

 

5,123,000

 

4,542,000

 

4,834,000

Medicare

 

258,000

 

172,000

 

161,000

Marketplace

 

346,000

 

281,000

 

271,000

Total

 

5,727,000

 

4,995,000

 

5,266,000

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

 

2024

 

2023

 

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

Premium

Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

 

Medicaid

 

$

7,492

 

$

775

 

89.7

%

 

$

6,349

 

$

734

 

88.4

%

Medicare

 

 

1,442

 

 

163

 

88.7

 

 

 

1,046

 

 

126

 

88.0

 

Marketplace

 

 

570

 

 

152

 

73.3

 

 

 

490

 

 

154

 

68.6

 

Consolidated

 

$

9,504

 

$

1,090

 

88.5

%

 

$

7,885

 

$

1,014

 

87.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE

(Dollars in millions)

 

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

 

 

Three Months Ended

 

 

March 31,

 

 

2024

 

2023

 

 

 

 

 

 

 

Unaudited

Medical claims and benefits payable, beginning balance

 

$

4,204

 

 

$

3,528

 

Components of medical care costs related to:

 

 

 

 

Current year

 

 

8,748

 

 

 

7,169

 

Prior year

 

 

(334

)

 

 

(298

)

Total medical care costs

 

 

8,414

 

 

 

6,871

 

Payments for medical care costs related to:

 

 

 

 

Current year

 

 

5,409

 

 

 

4,487

 

Prior year

 

 

2,879

 

 

 

2,358

 

Total paid

 

 

8,288

 

 

 

6,845

 

Acquired balances, net of post-acquisition adjustments

 

 

391

 

 

 

 

Change in non-risk and other payables

 

 

(150

)

 

 

270

 

Medical claims and benefits payable, ending balance

 

$

4,571

 

 

$

3,824

 

 

 

 

 

 

Days in Claims Payable (1)

 

 

49

 

 

 

48

 

__________________

 

 

 

 

(1)

 

The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

 

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

 

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

 

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

 

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

 

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

 

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

 

 

Three Months Ended March 31,

 

2024

 

2023

 

 

Amount

 

Per Diluted

Share

 

Amount

 

Per Diluted

Share

GAAP Net income

 

$

301

 

 

$

5.17

 

 

$

321

 

 

$

5.52

 

Adjustments:

 

 

 

 

 

 

 

 

Amortization of intangible assets

 

$

20

 

 

$

0.35

 

 

$

21

 

 

$

0.38

 

Acquisition-related expenses (1)

 

 

17

 

 

 

0.29

 

 

 

 

 

 

 

Other (2)

 

 

6

 

 

 

0.10

 

 

 

 

 

 

 

Subtotal, adjustments

 

 

43

 

 

 

0.74

 

 

 

21

 

 

 

0.38

 

Income tax effect

 

 

(10

)

 

 

(0.18

)

 

 

(5

)

 

 

(0.09

)

Adjustments, net of tax

 

 

33

 

 

 

0.56

 

 

 

16

 

 

 

0.29

 

Adjusted net income

 

$

334

 

 

$

5.73

 

 

$

337

 

 

$

5.81

 

__________________

 

 

 

 

 

 

 

 

(1)

 

Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.

(2)

 

The three months ended March 31, 2024 includes non-recurring litigation costs and one-time termination benefits.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)

2024 GUIDANCE

 

 

 

Amount

 

Per

Diluted

Share (2)

GAAP Net income

 

$

1,266

 

 

$

21.79

 

Adjustments:

 

 

 

 

Amortization of intangible assets

 

 

92

 

 

 

1.57

 

Acquisition-related expenses

 

 

33

 

 

 

0.58

 

Other

 

 

6

 

 

 

0.10

 

Subtotal, adjustments

 

 

131

 

 

 

2.25

 

Income tax effect (1)

 

 

(31

)

 

 

(0.54

)

Adjustments, net of tax

 

 

100

 

 

 

1.71

 

Adjusted net income

 

$

1,366

 

 

$

23.50

 

__________________

 

 

 

 

(1)

 

Income tax effect calculated at the statutory tax rate of approximately 23.9%.

(2)

 

Computations assume approximately 58.1 million diluted weighted average shares outstanding.

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.